Inflammation is a very complicated phenomenon and consist a part of the immune response which is divided to a natural phase followed by an adaptive one. Tissue injury is followed by a cascade of events leading to the inflammatory response which is divided in three phases. The first phase of inflammation is manifested by the activation of the local tissue macrophagues which exert their phagocytic action and the mast cells which liberate cytokines and vasoactive substances. Cytokines are divided in proinflammatory, chemokines and immunoregulatory ones. Proinflammatory cytokines trigger the second phase of inflammation while chemokines create a chemotactic current. Immunoregulatory cytokines prepare the adaptive phase of the immune response. A certain number of vasoactive substances mediate an initial local vasoconstriction aiming to restrict the cause of tissue injury. This vasoconstriction is followed by a broader local vasodilatation and an increased permeability of the vascular wall. These last events permit to the inflammatory cells and macromolecules to reach the site of tissue injury. Many vasoactive substances like istamine, bradykinine, prospaglandins, leukotrienes and nitric oxide participate in these actions. During the second phase of inflammation, blood cells following the chemotactic current move to the site of injury and start their phagocytic activity. The third phase of inflammation is connected with the tissue restoration.
. 2010 Apr 22;9(Suppl 1):S1. doi: 10.1186/1744-859X-9-S1-S1
Tissue injury and inflammation
Basileios Kokkas
1,✉
Basileios Kokkas
11st Department of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Greece
Find articles by Basileios Kokkas
11st Department of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Greece
✉
Corresponding author.
Supplement
1st International Congress on Neurobiology and Clinical Psychopharmacology and European Psychiatric Association Conference on Treatment Guidance
Konstantinos N Fountoulakis
Conference
19–22 November 2009
1st International Congress on Neurobiology and Clinical Psychopharmacology and European Psychiatric Association Conference on Treatment Guidance
Thessaloniki, Greece
Collection date 2010.
Copyright ©2009 Kokkas; licensee BioMed Central Ltd.
PMCID: PMC2991780 PMID: 25410142
